Overall rank by patents
#32,773
of 49,997 tracked assignees
USPTO PatentsView assignee record - 8 granted patents across 5 technology areas, recorded in grant years 2020–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61B (DIAGNOSIS; SURGERY; Identification).
The verdict
According to USPTO PatentsView, Ortho ranks #32,773 of 49,997 tracked US assignees by granted-patent volume, with 8 patents across 5 technology areas.
USPTO PatentsView assignee plate
Corpus R32773 · US Corporation #32,773 · 8 grants
GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · SPAN-YRS · BOOK-RICH
Nearest grant-volume peer: Orchid Exchange Inc. (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
Qualcomm Incorporated · highest
85 score
I D YOU · near
28 score
Hanmi Pharmaceutical · near
28 score
Mueller Sports… · near
28 score
Ortho Development · this assignee
28 score
Crystal Group · near
28 score
3D Lighting… · lowest
7 score
What this shows Ortho's Innovation Score is 27.7/100 (24th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Ortho Development Corporation is a focused PatentsView assignee: 5 CPC subclasses with 50% of grants classified under A61B (DIAGNOSIS; SURGERY; Identification). Peak complete grant year is 2020 (3 grants) versus a trough of 1 in 2024. By volume, Ortho sits between Orchid Exchange Inc. and Oso Perforating, LLC.
Ortho Development Corporation shows 3 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
Orchid Exchange Inc.
8 patents
Orexigen Therapeutics, Inc.
8 patents
Orgenesis Inc.
8 patents
Orth Consulting, LLC
8 patents
Orthodyne Electronics Corporation
8 patents
Ortiz and Associates Consulting, LLC
8 patents
Osborne Industries Inc.
8 patents
Oso Perforating, LLC
8 patents
Ortho Development Corporation
8 patents
What this shows Ortho holds 8 patents at rank #32,764, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
By rank, the assignees closest to #32,764 in granted patent volume.
Other assignees with the most granted patents in Ortho's primary technology class.
Two PlainPatent-derived peer sets for Ortho, neither rank-band nor same-CPC leaders (those blocks stay above).
Nearest assignees by Innovation Score (28 here).
Ortho's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
28 24th percentile higher than 24% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Teal-shaded recent years (2020–present) versus the 2020–2019 baseline. Full figures in the table below.
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2020 | 3 | 37.5% |
| 2021 | 2 | 25.0% |
| 2023 | 2 | 25.0% |
| 2024 | 1 | 12.5% |
Top 5 of 5 technology areas
Overall rank by patents
#32,773
of 49,997 tracked assignees
27.7 out of 100
What to do with this data
Ortho Development Corporation's patent record in context - here's where to go next.
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.